Humana · Off Label NCCN · US health-plan appeal rights

Off Label NCCN denied for failing step therapy by Humana?

Q: How long do I have to appeal a Humana Off Label NCCN denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-09

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Humana typically requires

Humana's specific coverage criteria for off label nccn are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Humana Oncology Pharmacy Prior Authorization Criteria (Medicare Advantage tied to CMS NCDs/LCDs)

The Humana angle on Off Label NCCN

## Why Humana Applied Step-Therapy to This Off-Label (NCCN-Supported) Drug

Step-therapy (also called "fail-first") means Humana requires you to try and fail one or more lower-cost or preferred drugs before it will approve the requested agent. For off-label oncology drugs with NCCN Compendium support, step-therapy requirements are frequently inappropriate and may conflict with your state's step-therapy override laws — a growing number of states have enacted legislation specifically limiting step-therapy in oncology and other serious conditions.

## Why This Is Appealable

Step-therapy overrides are available when (1) you have already tried and failed the required step drugs, (2) the required step drugs are clinically contraindicated or inappropriate for your specific disease subtype or molecular profile, or (3) delaying the requested drug would cause irreversible harm. NCCN protocols often specify a preferred sequence or identify situations where first-line alternatives are not appropriate; your prescriber's documentation of why the step should be skipped is the foundation of a successful appeal.

## Federal Appeal Framework

Step-therapy exception / override request: Most plans have a dedicated exception process. File this first, simultaneous with the formal appeal.
Internal appeal: File within the timeframe on your EOB. Cite your state's step-therapy override law if one exists, and Humana's own step-therapy exception criteria.
External review (ACA §2719): After a final internal denial, an independent IRO reviews whether the step-therapy requirement is appropriate for your clinical situation. Standard window is approximately four months; expedited review is available for urgent cases.
ERISA §503 (employer plans): Request the specific step-therapy clinical criteria and the list of required step drugs.

## Documentation to Gather

1. List of required step drugs — obtain from Humana exactly which drugs must be tried first and in what order. 2. Prior treatment history — for each required step drug: dates of use, doses (from your records), and documented reason for failure or discontinuation. 3. Clinical rationale for skipping a step — if a required step drug was never tried, your prescriber must document why it is clinically inappropriate (e.g., disease subtype for which it is not recommended per NCCN, specific patient factors making it unsuitable). 4. NCCN compendium printout — showing the applicable treatment sequence or supporting the skipped step. 5. Prescriber medical-necessity letter — addressing each required step drug individually and explaining why the requested agent is now medically necessary. 6. State step-therapy law — check with a patient advocate whether your state has enacted step-therapy override protections.

## Criteria-Mapping Structure

Create a row for each drug in Humana's required step sequence. Column one: the step drug. Column two: date tried / reason not tried. Column three: outcome or clinical rationale. Attach supporting chart notes as exhibits. This structured format makes it easy for the reviewing clinician to verify step completion or the medical basis for skipping each step.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Humana appeals

Other insurers on Off Label NCCN

Aetna denied for failing step therapy of Off Label NCCN

Other denial reasons for Humana Off Label NCCN

denied as not medically necessary denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-09. Editorial standards: denialhelp.com/authors.